NASDAQ:SVRA

Savara Stock Insider Trading

Healthcare > Biotechnology

Buy SVRA

*Your capital is at risk

$5.78

+0.0900 (+1.58%)

At Close: Jun 23, 2026

Savara Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -36.65. In total, the insiders bought 5.03M and sold 1.47M SVRA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-36.65
● Buy	5.03M shares
● Sell	1.47M shares
72% Buy Activity Weak Negative Correlation
Sell Signal Medium Confidence Jun 22, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -36.65. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 22, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	56 937 Value: $63.2K
Jun 22, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	75 000 Value: $119.3K
Jun 22, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	218 750 Value: $330.3K
Jun 22, 2026 Sell	Common Stock S-Sale	Lowrance David L Chief Financial Officer	C-Suite Officer	394 528 Value: $2.24M
Jun 22, 2026 Buy	Common Stock M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	75 000 Value: $119.3K
Jun 22, 2026 Buy	Common Stock M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	129 350 Value: $159.1K
Jun 22, 2026 Buy	Common Stock M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	56 937 Value: $63.2K
Jun 22, 2026 Sell	Common Stock F-InKind	Lowrance David L Chief Financial Officer	C-Suite Officer	10 114 Value: $55.6K
Jun 22, 2026 Buy	Common Stock M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	12 500 Value: $55.6K
Jun 22, 2026 Buy	Common Stock M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	218 750 Value: $330.3K
Jun 22, 2026 Buy	Common Stock M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	87 650 Value: $293.6K
Jun 22, 2026 Sell	Common Stock F-InKind	Lowrance David L Chief Financial Officer	C-Suite Officer	53 387 Value: $293.6K
Jun 22, 2026 Sell	Common Stock F-InKind	Lowrance David L Chief Financial Officer	C-Suite Officer	60 057 Value: $330.3K
Jun 22, 2026 Sell	Common Stock F-InKind	Lowrance David L Chief Financial Officer	C-Suite Officer	11 491 Value: $63.2K
Jun 22, 2026 Sell	Common Stock F-InKind	Lowrance David L Chief Financial Officer	C-Suite Officer	28 928 Value: $159.1K
Jun 22, 2026 Sell	Common Stock F-InKind	Lowrance David L Chief Financial Officer	C-Suite Officer	21 682 Value: $119.3K
Jun 22, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	87 650 Value: $293.6K
Jun 22, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	12 500 Value: $55.6K
Jun 22, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	129 350 Value: $159.1K
Mar 18, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	80 684 Value: $121.8K
Mar 18, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	75 000 Value: $119.3K
Mar 18, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	24 850 Value: $83.2K
Mar 18, 2026 Buy	Common Stock M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	80 684 Value: $121.8K
Mar 18, 2026 Buy	Common Stock M-Exempt	Lowrance David L Chief Financial Officer	C-Suite Officer	75 000 Value: $119.3K
Mar 18, 2026 Sell	Common Stock F-InKind	Lowrance David L Chief Financial Officer	C-Suite Officer	9 485 Value: $47.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SAVARA INC

Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas....

Read Full Profile Here